BNP Paribas Financial Markets’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$381K Buy
72,241
+57,371
+386% +$302K ﹤0.01% 3901
2026
Q1
$62.2K Sell
14,870
-77,580
-84% -$373K ﹤0.01% 4586
2025
Q4
$445K Buy
92,450
+30,443
+49% +$147K ﹤0.01% 3634
2025
Q3
$314K Buy
62,007
+55,021
+788% +$243K ﹤0.01% 3793
2025
Q2
$28.2K Buy
6,986
+2,749
+65% +$8.95K ﹤0.01% 4467
2025
Q1
$11.6K Sell
4,237
-3,815
-47% -$13.7K ﹤0.01% 4684
2024
Q4
$34.2K Buy
+8,052
New +$30.7K ﹤0.01% 4568

Other funds holding SRTA

BNP Paribas Financial Markets's SRTA Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Strata Critical Medical Inc (SRTA) stake by 386% in Q2 2026, buying an estimated $302K and bringing the position to 72,241 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #3901.

BNP Paribas Financial Markets first reported a position in SRTA in Q4 2024 and has held it in 7 quarters since. The position peaked at $445K in Q4 2025. 132 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • BNP Paribas Financial Markets held 72,241 shares of Strata Critical Medical Inc worth $381K as of Q2 2026.
  • BNP Paribas Financial Markets bought 57,371 Strata Critical Medical Inc shares in Q2 2026, an estimated $302K.
  • Strata Critical Medical Inc made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #3901 holding.
  • BNP Paribas Financial Markets first reported a position in Strata Critical Medical Inc in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Strata Critical Medical Inc position peaked at $445K in Q4 2025.
  • 132 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.